22 May 2013
Keywords: roche, initiates, ph, ii, genmab, r1507, denmark
Article | 07 January 2008
Denmark's Genmab A/S says that its partner, Swiss drug major Roche, has initiated a Phase II clinical study of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
7 January 2008
14 January 2008
21 May 2013
© 2013 thepharmaletter.com